Risk factors for development of delayed urticarial reactions in the phase II trial of HER2 peptide vaccines plus GM-CSF versus GM-CSF alone in high-risk breast cancer patients to prevent recurrence.
Alfred F Trappey
No relevant relationships to disclose
John S. Berry
No relevant relationships to disclose
Timothy J Vreeland
No relevant relationships to disclose
Diane F. Hale
No relevant relationships to disclose
Alan K. Sears
No relevant relationships to disclose
Sathibalan Ponniah
No relevant relationships to disclose
Sonia A. Perez
No relevant relationships to disclose
Guy T. Clifton
No relevant relationships to disclose
Michael Papamichail
No relevant relationships to disclose
Nathan M. Shumway
No relevant relationships to disclose
Elizabeth Ann Mittendorf
No relevant relationships to disclose
George Earl Peoples
Consultant or Advisory Role - Antigen Express